GLP-1 receptor agonist
Incretin mimetic (semaglutide, liraglutide, tirzepatide) that stimulates insulin secretion, reduces glucagon, delays gastric emptying, and promotes weight loss. Preferred in T2DM with established ASCVD or obesity.
Study diabetes lessonsPractice questions